Critical Metals Stock Surges on Greenland Facility Approval
Critical Metals jumps 12% after approving construction of Arctic storage facility in Greenland for its Tanbreez rare earth project, valued at $3 billion NPV.
NOTRELOAD AI
GameStop's Ryan Cohen Gets $24B+ Performance Package Tied to Stock Price & Profits
GameStop (GME) CEO Ryan Cohen's new compensation plan offers zero guaranteed pay—only massive stock options if the company hits ambitious market cap and EBITDA targets through 2026.
William Blair Starts Coverage on Vertical Aerospace With Bullish View
William Blair begins coverage of Vertical Aerospace with an Outperform rating, highlighting its strong position in the growing urban air mobility market.
Oppenheimer & H.C. Wainwright Bullish on LEGN, JBIO, CGEN
Oppenheimer and H.C. Wainwright start coverage on Legend Biotech, Jade Biosciences, and Compugen with bullish ratings and price targets, highlighting growth potential in CAR-T therapy, autoimmune, and immuno-oncology pipelines.
FDA Grants Priority Review for Atacicept IgAN Treatment
Vera Therapeutics receives FDA Priority Review for atacicept, a potential first-in-class treatment for IgA nephropathy with a decision expected by July 2026.
Major Biotech Upgrades and Coverage Initiations: Regeneron, Erasca, Protara, Design Therapeutics, Oric
Bank of America and Piper Sandler make bullish moves on top biotech stocks, including Regeneron, Erasca, Protara, Design Therapeutics, and Oric, highlighting growth potential, new drug updates, and pipeline opportunities.